Teniposide Injection

Form: Injection

Strength: 50 mg/10 mL (5 mg/mL)

Reference Brands: Vumon.(US & EU)

Category: Oncology Cancer Care

Teniposide Injection (Vumon) is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL) and neuroblastoma. Available in the U.S. and EU, Teniposide is typically supplied as 50 mg/10 mL (5 mg/mL) for intravenous infusion. As a topoisomerase II inhibitor, it interferes with DNA replication in cancer cells, preventing their division. This injectable formulation is essential in multi-drug chemotherapy regimens and is administered under the supervision of healthcare professionals in clinical settings. It requires careful handling due to potential side effects, including bone marrow suppression and liver toxicity, making it suitable for B2B pharmaceutical distribution in oncology.